Gastric Voume Assessment for Aspiration Risk in OB ERAS Patients
Pre-Operative Gastric Volume Assessment Following Carbohydrate-Loading in Obstetrical Patients Undergoing Elective Cesarean Section: A Randomized Clinical Pilot Study
In recent years, human and animal studies have found that carbohydrate-loading prior to surgery leads to improved response to surgical stress and improved postoperative well-being when compared to traditional fasting guidelines. Such positive findings have lead to the increased use of preoperative intake of carbohydrate rich drinks prior to elective surgeries.
However, one of the biggest risks during surgery when a patient is asleep is having stomach contents come up into the lungs. For this reason, a stomach that is empty or has minimal amount of contents is safest. Historically, patients have been instructed not to eat or drink for 8 hours before surgery because it was thought to lower the risk of having fluid or contents in the stomach. This is the current practice patients are asked to follow before undergoing a C-section. However, non-pregnant patients undergoing other surgeries are instructed to have carbohydrate-rich drinks because of the potential benefits. Using ultrasound, the abdomen can be simply scanned to see if there are stomach contents present before surgery. This can allow for the potential determination of what the aspiration risk may be.
What the investigators want to do is look at the safety of using carbohydrate-loading in patients having a C-section. The investigators want to make sure that patients who follow carbohydrate-loading by having a clear, sugary drink 3 hours before a C-section are not at greater risk of having a large amount of stomach contents and be at higher risk of aspirating. This will be done by taking an ultrasound scan of the stomach that will tell the investigators if there are contents in the stomach and whether there is a risk of aspiration.
Patients having an elective C-section will be randomized into two groups. The first group will follow carbohydrate-loading by having a drink of apple juice or cranberry juice cocktail the night before (800mL) and 3 hours before (400mL) the C-section. The second group will follow standard practice of not eating or drinking less than 8 hours prior to surgery. An anesthesiologist will ultrasound the stomach 1 hour before the scheduled procedure time. The first ultrasound will be completed in the supine position (lying on back). The second will be done in the right lateral decubitus position (lying on right side). This should not take more than 5-10 minutes total.
Panoramica dello studio
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- Foothills Medical Centre
-
Calgary, Alberta, Canada, T1Y 6J4
- Peter Lougheed Centre
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Non-laboring pregnant women
- ≥36 weeks gestational age
- scheduled elective cesarean delivery
- ≥18 years of age
- ASA physical status I to III
- weight 50 to 120 kg
- height ≥150 cm
- Ability to understand the rationale of the study assessments
Exclusion Criteria:
- multiple gestation
- abnormal anatomy of the upper gastrointestinal tract
- gestational diabetes or pre-existing diabetes mellitus
- previous surgical procedures on the esophagus, stomach, or upper abdomen
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Selezione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Standard Fasting Group
Ultrasound scan of gastric antrum 1 hour prior to procedure.
Patients assigned to this group will follow standard fasting procedures of no eating or drinking 8 hours prior to C-section.
|
Gastric ultrasound of the stomach antrum to assess contents 1 hour prior to C-section surgery.
Scans will be completed in both supine (lying on back) and right lateral decubitus (positions) positions.
The completion of both scans will take 5-10 minutes total
|
|
Sperimentale: Carbohydrate Loading Group
Ultrasound scan of gastric antrum 1 hour prior to procedure. Patients assigned to this group must stop eating 8 hours prior to their scheduled C-section time. The night before their C-section they must drink 800mL of 100% apple juice (not from concentrate) OR 800mL of cranberry juice cocktail, not both The day of their C-section, starting 3 hours before surgery and to be finished 2 hours before surgery time, patients must drink 400mL of 100% apple juice OR 400mL of cranberry juice cocktail, not both Please note:
|
Gastric ultrasound of the stomach antrum to assess contents 1 hour prior to C-section surgery.
Scans will be completed in both supine (lying on back) and right lateral decubitus (positions) positions.
The completion of both scans will take 5-10 minutes total
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of Grade 2 antrum
Lasso di tempo: 1 hour prior to C-section delivery
|
Clear fluid is evident in antrum in both supine and right lateral decubitus scanning positions
|
1 hour prior to C-section delivery
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of Grade 0 antrum
Lasso di tempo: 1 hour prior to C-section
|
Antrum appears empty in both supine and right lateral decubitus scanning positions
|
1 hour prior to C-section
|
|
Incidence of Grade 1 antrum
Lasso di tempo: 1 hour prior to C-section
|
Antrum appears empty in supine position, but clear fluid is visible in right lateral decubitus position
|
1 hour prior to C-section
|
|
Cross-sectional antral area
Lasso di tempo: 1 hour prior to C-section
|
Cross-sectional area measurement of the gastric antrum
|
1 hour prior to C-section
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- REB17-2345
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .